Correlation Between Volaris and Mink Therapeutics

Can any of the company-specific risk be diversified away by investing in both Volaris and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Volaris and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Volaris and Mink Therapeutics, you can compare the effects of market volatilities on Volaris and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Volaris with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Volaris and Mink Therapeutics.

Diversification Opportunities for Volaris and Mink Therapeutics

-0.39

Correlation Coefficient

Volaris  Mink Therapeutics

Very good diversification

The 3 months correlation between Volaris and Mink is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Volaris and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Volaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Volaris are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Volaris i.e., Volaris and Mink Therapeutics go up and down completely randomly.

Pair Corralation between Volaris and Mink Therapeutics

Given the investment horizon of 90 days Volaris is expected to generate 0.35 times more return on investment than Mink Therapeutics. However, Volaris is 2.87 times less risky than Mink Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Mink Therapeutics is currently generating about -0.26 per unit of risk. If you would invest  758.00  in Volaris on September 27, 2024 and sell it today you would earn a total of  18.00  from holding Volaris or generate 2.37% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Volaris  vs.  Mink Therapeutics

Volaris

Risk-Adjusted Performance

10 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Volaris are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Volaris unveiled solid returns over the last few months and may actually be approaching a breakup point.

Mink Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mink Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward-looking signals remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Volaris and Mink Therapeutics

The main advantage of trading using opposite Volaris and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Volaris position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.

The idea behind Volaris and Mink Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.